Rwanda : BioNTech vaccine manufacturing plant to be launched next month

The state-of-the-art manufacturing plant for mRNA-based vaccines, developped by German biotechnology company BioNTech, will be inaugurated on December 18.

A memorandum of understanding signed between the two parties in 2021 led to the establishment of a BioNTech facility in the Special Economic Zone in Gasabo District in June 2022.

The Rwanda-based facility covers an area of about 30,000 square metres. It is equipped with BioNTainers (for the production of mRNA and formulated bulk drug products).